Genialis is a precision oncology company helping the most promising molecules become life-saving medicines. We are creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are transforming medicine through data.
Looking for a particular Genialis employee's phone or email?
The Genialis annual revenue was $10.4 million in 2026.
Rafael Rosengarten is the CEO of Genialis.
23 people are employed at Genialis.
Genialis is based in Boston, Massachusetts.
The NAICS codes for Genialis are [5417, 54, 541, 54171, 541713].
The SIC codes for Genialis are [873, 87].